Impact of Antiretroviral Therapy Duration on Hematology Profile in HIV Patients at Buntok Health Center, Indonesia
DOI:
https://doi.org/10.35916/thmr.v7i1.128Abstract
HIV/AIDS is a global health challenge that requires long-term therapy, one of which is the use of Antiretroviral (ARV). ARV therapy has a significant impact on the patient's hematological profile, such as hemoglobin, hematocrit, erythrocytes, leukocytes, and platelets. However, the long-term effects of ARV therapy on hematological profiles in Indonesia, especially in the Central Kalimantan region, have not been widely studied. This study aims to analyze the relationship between the length of ARV therapy and hematological profile in HIV patients at Buntok health center. This study used an analytic survey design with a cross-sectional approach. The study sample involved 29 HIV patients undergoing ARV therapy, taken by total sampling. Data were obtained from medical records and laboratory examinations and then analyzed using the Spearman correlation test to test the relationship between variables. The results showed a significant association between the duration of ARV therapy and the levels of hemoglobin (p = 0.005), hematocrit (p = 0.001), erythrocytes (p = 0.000), and platelets (p = 0.023). However, no significant relationship was found between the duration of ARV therapy and the number of leukocytes (p = 0.063). The correlation found was negative, indicating that the longer the ARV therapy, the more certain hematological parameters decreased. It is concluded that the duration of ARV therapy is associated with changes in the hematological profile of HIV patients. These findings suggest the importance of routine monitoring of hematologic profiles to detect adverse effects of ARV therapy, especially in patients on long-term therapy.
References
Global Health Observatory (GHO) data. WHO | HIV/AIDS. WHO. 2020;1–14
UNAIDS. Global HIV and AIDS statistics 2020 Fact sheet. Glob HIV AIDS statistics, World AIDS day 2020 Fact Sheet. 2020;1: 1–6.
Saha D, Kini JR, Subramaniam R. A study of the hematological profile of human immunodeficiency virus positive patients in coastal South Indian Region. J Med Sci. 2015;35(5):190–3.
Fekene TE, Juhar LH, Mengesha CH, Worku DK. Prevalence of cytopenias in both HAART and HAART naïve HIV infected adult patients in Ethiopia: A cross sectional study. BMC Hematol .2018; 18(1):1–11.
Katemba C, Muzoora C, Muwanguzi E, Mwambi B, Atuhairwe C, Taremwa IMM. Hematological abnormalities in HIV-antiretroviral therapy naïve clients as seen at an immune suppression syndrome clinic at Mbarara regional referral hospital, southwestern Uganda. J Blood Med. 2018;9.
Ebonyi AO, Oguche S, Ochoga MO, Agbaji OO, Anejo-Okopi JA, Abah IO. Changes in the haematological parameters of HIV-1 infected children at 6 and 12 months of antiretroviral therapy in a large clinic cohort, North-Central Nigeria. BMC Hematol. 2017
Kumar MB, Thippeswamy T, Shankar R, Prathima C. Hematological Abnormalities in Early and Advanced HIV Infection Patients. Int J Sci Study. 2016;3(11):1–5.
Vishnu P, Aboulafia DM. Haematological manifestations of human immune deficiency virus infection. Br J Haematol. 2015;171(5):695–709.
Raadsen M, du Toit J, Langerak T, van Bussel B, van Gorp E, Goeijenbier M. Thrombocytopenia in virus infections. J Clin Med. 2021;10(4):1–33.
Bhardwaj S, Almaeen A, Ahmed Wani F, Thirunavukkarasu A. Hematologic derangements in HIV/AIDS patients and their relationship with the CD4 counts: a cross-sectional study. BMC Hematol. 2020;13(4):756–63.
Vecchiet J, Iachininoto MG, Capodimonti S, Nuzzolo ER, Falasca K, Martini M. Effect of antiviral therapy on pro-angiogenic hematopoietic and endothelial progenitor cells in HIV-infected people. Thromb Res. 2013;131(3):238–43.
Assefa M, Abegaz WE, Shewamare A, Medhin G, Belay M. Prevalence and correlates of anemia among HIV infected patients on highly active anti-retroviral therapy at Zewditu Memorial Hospital, Ethiopia. BMC Hematol. 2015;15(1):2–8.
Lestari I, Windartik E, Wijaya G. Hubungan lama penggunaan obat arv terhadap kadar hemoglobin pada penderita HIV/AIDS di poli VCT RSUD Prof. Dr. Soekandar kabupaten Mojokerto. Jurnal Kep. 2016;5(2):73-6
Kementerian Kesehatan Republik Indonesia. Peraturan Menteri Kesehatan Nomor 23 Tahun 2022 tentang Penanggulangan Human Immunodeficiency Virus, Acquired Immuno-Deficiency Syndrome, dan Infeksi Menular Seksual. Jakarta: Kementerian Kesehatan Republik Indonesia; 2022. https://peraturan.bpk.go.id/Details/245543/ permenkes-no-23-tahun-2022
Duguma N, Tesfaye Kiya G, Adissu Maleko W, Bimerew LG. Hematological parameters abnormalities and associated factors in HIV-positive adults before and after highly active antiretroviral treatment in Goba Referral Hospital, southeast Ethiopia: A cross-sectional study. SAGE Open Medicine. 2021;9
Marchionatti A, Parisi MM. Anemia and thrombocytopenia in people living with HIV/AIDS: a narrative literature review. Int Health. 2021; 13(2): 98–109.
Berhane Y, Haile D, Tolessa T. Anemia in HIV/AIDS Patients on antiretroviral treatment at Ayder Specialized Hospital, Mekele, Ethiopia: a case-control study. J Blood Med. 2020; 11: 379–387
Volberding PA, Levine AM, Dieterich D. Anemia in HIV infection: clinical impact and evidence-based management strategies. Clin Infect Dis. 2004; 38(10): 1454–1463.
Gudina A, Wordofa M, Urgessa F. Immuno-hematological parameters among adult HIV patients before and after initiation of Dolutegravir based antiretroviral therapy, Addis Ababa, Ethiopia. PLoS One. 2024 Oct 31;19(10): e0310239
Rezaei E, Ebrahim-Saraie HS, Heidari H, Ghane P, Rezaei K, Manochehri J. Impact of vitamin supplements on HAART related hematological abnormalities in HIV-infected patients. Med J Islam Repub Iran. 2016.
Damtie S, Workineh L, Kiros T, Eyayu T, Tiruneh T. Hematological abnormalities of adult hiv-infected patients before and after initiation of highly active antiretroviral treatment at debre tabor comprehensive specialized hospital, northcentral ethiopia: A cross-sectional study. HIV/AIDS—BMC Hematol. 2021; 13:477–84.
